Gonadotropin-Releasing Hormone Blockers and Cardiovascular Disease Risk: Analysis of Prospective Clinical Trials of Degarelix-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Gonadotropin-Releasing Hormone Blockers and Cardiovascular Disease Risk: Analysis of Prospective Clinical Trials of Degarelix

Published:2011-11 Issue:5 Volume:186 Page:1835-1842
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Smith Matthew R.¹,Klotz Laurence²,van der Meulen Egbert³,Colli Enrico³,Tankó László B.³

Affiliation:

1. Hematology-Oncology, Massachusetts General Hospital Cancer Center, Boston, Massachusetts

2. Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada

3. Ferring Pharmaceuticals A/S, Global Clinical R&D, Copenhagen, Denmark

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference26 articles.

1. Testosterone surge: rationale for gonadotropin-releasing hormone blockers?;Van Poppel;Urology,2008

2. Hormonal therapy for metastatic prostate cancer: issues of timing and total androgen ablation;Cookson;South Med J,1994

3. Androgen deprivation therapy for the treatment of prostate cancer: consider both benefits and risks;Isbarn;Eur Urol,2009

4. Androgen-deprivation therapy in prostate cancer and cardiovascular risk;Levine;Circulation,2010

5. Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer;Keating;J Clin Oncol,2006

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Androgen Deprivation Therapy and Risk of Cardiovascular Disease in Patients With Prostate Cancer Based on Existence of Cardiovascular Risk;Journal of the National Comprehensive Cancer Network;2023-02

2. Appropriateness and complications of androgen deprivation therapy for prostate cancer: Can we do better? A retrospective observational analysis from a referral center;Urologia Journal;2023-01-26

3. Association between atherogenic lipids and GnRH agonists for prostate cancer in men with T2DM: a nationwide, population-based cohort study in Sweden;British Journal of Cancer;2022-12-15

4. Cardiovascular safety of hormone therapy for prostate cancer;Cancer Urology;2022-12-09

5. Impact of Androgen Deprivation Therapy on Cardiovascular Outcomes in Prostate Cancer;Société Internationale d’Urologie Journal;2022-07-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3